Arbutus Biopharma (ABUS) PT Raised to $8.50 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce raised the price target on Arbutus Biopharma (NASDAQ: ABUS) to $8.50 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
